Tag:

Treatments

A clinician traces the evolution of cystic fibrosis, from rudimentary treatments and very limited survival to major advances in care, research and quality of life, while stressing that despite remarkable progress, the fight is not yet over.

In people with cystic fibrosis, antibiotic allergies are common due to repeated treatments, require a thorough diagnosis, and can sometimes be circumvented by desensitization when the antibiotic is essential.

The article presents major advances in research targeting the CFTR protein, with innovative therapies (ivacaftor, lumacaftor and combinations) that pave the way for a gradual correction of the very cause of cystic fibrosis.

Vascular access is essential for intravenous treatment for cystic fibrosis, but each type of catheter has benefits and risks that should be well understood in order to prevent complications.

The year 2017 marked a major turning point in cystic fibrosis, with promising advances towards combination therapies capable of correcting the genetic defect in the majority of people affected.

A critical look at therapeutic progress and inequalities in access to cystic fibrosis treatments.